Retrovir Capsules

— THERAPEUTIC CATEGORIES —
  • Viral infections

Retrovir Capsules Generic Name & Formulations

General Description

Zidovudine 100mg.

Pharmacological Class

Nucleoside analogue (reverse transcriptase inhibitor).

How Supplied

Tabs—contact supplier; Caps—100; Syrup—240mL; IV (20mL/vial)—1, 5

Manufacturer

Generic Availability

YES

Retrovir Capsules Indications

Indications

HIV-1 infection, in combination with other antiretroviral agents. Prevention of maternal-fetal HIV-1 transmission.

Retrovir Capsules Dosage and Administration

Adult

≥18yrs: 300mg twice daily. Renal impairment (CrCl <15mL/min) or on dialysis: 100mg every 6–8hrs. Prevention of maternal-fetal HIV or vertical transmission, severe anemia and/or neutropenia: see full labeling.

Children

<6wks and/or for vertical transmission: see full labeling. 4wks to <18yrs: (4 to <9kg): 24mg/kg/day (12mg/kg twice daily or 8mg/kg 3 times daily); (≥9 to <30kg): 18mg/kg/day (9mg/kg twice daily or 6mg/kg 3 times daily); (≥30kg): 600mg/day (300mg twice daily or 200mg 3 times daily). Alternative dosing based on BSA: 480mg/m2/day (240mg/m2 twice daily or 160mg/m2 3 times daily).

Retrovir Capsules Contraindications

Not Applicable

Retrovir Capsules Boxed Warnings

Boxed Warning

Hematological toxicity. Myopathy. Lactic acidosis and severe hepatomegaly with steatosis.

Retrovir Capsules Warnings/Precautions

Warnings/Precautions

Risk of hematologic toxicity/bone marrow suppression; monitor CBCs esp. in advanced HIV-1 disease; interrupt dose if anemia or neutropenia occurs. Myopathy/myositis with prolonged use. Suspend if lactic acidosis or pronounced hepatotoxicity (eg, hepatomegaly, steatosis) occurs. Monitor for lipoatrophy; use alternatives if suspected. Severe renal impairment: reduce dose (see Adult). Hepatic impairment or cirrhosis: monitor for hematologic toxicity. Latex allergy (IV). Women. Obesity. Elderly. Pregnancy. Nursing mothers: not recommended.

Retrovir Capsules Pharmacokinetics

See Literature

Retrovir Capsules Interactions

Interactions

Avoid concomitant stavudine, doxorubicin, nucleoside analogues (eg, ribavirin). Increased hematologic toxicity with ganciclovir, interferon alpha, ribavirin, other bone marrow suppressants or cytotoxic drugs. Monitor for treatment-associated toxicities (eg, hepatic decompensation) with interferon alpha with or without ribavirin.

Retrovir Capsules Adverse Reactions

Adverse Reactions

Headache, malaise, nausea, vomiting, anorexia; neutropenia, anemia, myopathy, lactic acidosis, severe hepatomegaly with steatosis, immune reconstitution syndrome, pancreatitis, lipoatrophy. Children: also fever, cough.

Retrovir Capsules Clinical Trials

See Literature

Retrovir Capsules Note

Not Applicable

Retrovir Capsules Patient Counseling

See Literature